Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker

Serum thymidine kinase 1 activity in breast cancer

(2017) Benjamin Nisman et al.   Cancer Biomarkers

Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker

(2014) Kiran Kumar Jagarlamudi et al.   BMC Veterinary Research

High levels of inactive thymidine kinase 1 polypeptide detected in sera from dogs with solid tumours by immunoaffinity methods: Implications for in vitro diagnostics

(2013) J. Kiran Kumar et al.   VETERINARY JOURNAL

Quaternary structures of recombinant, cellular, and serum forms of Thymidine Kinase 1 from dogs and humans

(2012) Sharif Hanan et al.   BMC BIOCHEMISTRY

Comparison of diagnostic and prognostic performance of two assays measuring thymidine kinase 1 activity in serum of breast cancer patients

(2012) Benjamin Nisman et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

A sensitive and kinetically defined radiochemical assay for canine and human serum thymidine kinase 1 (TK1) to monitor canine malignant lymphoma

(2012) H. Sharif et al.   VETERINARY JOURNAL

Histological, molecular and functional subtypes of breast cancers

(2011) Gautam K. Malhotra et al.   CANCER BIOLOGY & THERAPY

Serological Thymidine Kinase 1 is a Biomarker for Early Detection of Tumours—A Health Screening Study on 35,365 People, Using a Sensitive Chemiluminescent Dot Blot Assay

(2011) Zhi Heng Chen et al.   SENSORS

Serological thymidine kinase 1 is a prognostic factor in oesophageal, cardial and lung carcinomas

(2010) Zhishan Li et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1,247 cancer patients in routine clinical settings

(2010) Yan Chen et al.   International Journal of Clinical Oncology

Thymidine Kinase 1 is a Potential Marker for Prognosis and Monitoring the Response to Treatment of Patients with Breast, Lung, and Esophageal Cancer and Non-Hodgkin's Lymphoma

(2010) E. He et al.   NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS

Thymidine kinase 1 expression defines an activated G1 state of the cell cycle as revealed with site-specific antibodies and ArrayScan™ assays

(2009) Fabio Gasparri et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

An Update of the Gleason Grading System

(2009) Jonathan I. Epstein   JOURNAL OF UROLOGY

Elevated levels of thymidine kinase 1 peptide in serum from patients with breast cancer

(2009) Lena Carlsson et al.   UPSALA JOURNAL OF MEDICAL SCIENCES